| (+)-alpha-viniferin | multiple interactions | EXP | | 6480464 | alpha-viniferin inhibits the reaction [IRF1 protein results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:20424383 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:735989 | 6480464 | Dinitrochlorobenzene results in increased expression of IRF1 mRNA | CTD | PMID:20146380 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735989 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:19684285 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735989 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:19684285 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of IRF1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2920 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IRF1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:15667827 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:19684285 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:19684285 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735989 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:20106945 PMID:19684285 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:15667827 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735989 | 6480464 | [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in increased expression of IRF1 mRNA | CTD | PMID:14761676 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA | CTD | PMID:15667827 more ... |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] | CTD | PMID:20737476 |
| 2-nitrofluorene | increases expression | ISO | RGD:2920 | 6480464 | 2-nitrofluorene results in increased expression of IRF1 mRNA | CTD | PMID:14600272 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:735989 | 6480464 | [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in increased expression of IRF1 mRNA | CTD | PMID:14761676 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:2920 | 6480464 | Oxazolone results in increased expression of IRF1 mRNA | CTD | PMID:21893156 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:2920 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IRF1 mRNA | CTD | PMID:14600272 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | multiple interactions | ISO | RGD:735989 | 6480464 | Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IRF1 protein] | CTD | PMID:16085646 PMID:16636311 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | ISO | RGD:735989 | 6480464 | Am 580 results in increased expression of IRF1 protein | CTD | PMID:16085646 PMID:16636311 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases activity | ISO | RGD:735989 | 6480464 | Am 580 results in increased activity of IRF1 protein | CTD | PMID:16636311 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | ISO | RGD:735989 | 6480464 | Am 580 results in increased expression of IRF1 protein | CTD | PMID:16636311 PMID:16085646 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | multiple interactions | ISO | RGD:735989 | 6480464 | Am 580 affects the localization of [Am 580 results in increased expression of IRF1 protein]; more ... | CTD | PMID:16636311 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:735989 | 6480464 | Fenretinide results in increased expression of IRF1 mRNA | CTD | PMID:15958647 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:735989 | 6480464 | decitabine results in increased expression of IRF1 mRNA | CTD | PMID:17785578 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | alitretinoin results in increased expression of IRF1 | CTD | PMID:16636311 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | alitretinoin results in increased expression of IRF1 protein | CTD | PMID:16085646 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | alitretinoin results in increased expression of IRF1 mRNA | CTD | PMID:17229644 |
| acetylsalicylic acid | increases expression | ISO | RGD:735989 | 6480464 | Aspirin results in increased expression of IRF1 mRNA | CTD | PMID:15928584 |
| acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of IRF1 mRNA | CTD | PMID:18515264 |
| actinomycin D | multiple interactions | ISO | RGD:735989 | 6480464 | Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]] | CTD | PMID:16085646 |
| actinomycin D | multiple interactions | ISO | RGD:735989 | 6480464 | Dactinomycin inhibits the reaction [Tretinoin results in increased expression of IRF1 mRNA] | CTD | PMID:16636311 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] | CTD | PMID:20737476 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:735989 | 6480464 | Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]]; more ... | CTD | PMID:16085646 |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 mRNA | CTD | PMID:16636311 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 protein | CTD | PMID:16085646 PMID:16636311 |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 mRNA | CTD | PMID:16636311 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 mRNA | CTD | PMID:16636311 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 mRNA | CTD | PMID:16166294 more ... |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:735989 | 6480464 | Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of IRF1 protein] | CTD | PMID:16636311 PMID:16085646 |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 protein | CTD | PMID:16636311 PMID:16085646 |
| all-trans-retinoic acid | increases expression | ISO | RGD:735989 | 6480464 | Tretinoin results in increased expression of IRF1 mRNA | CTD | PMID:17218384 more ... |
| all-trans-retinoic acid | increases activity | ISO | RGD:735989 | 6480464 | Tretinoin results in increased activity of IRF1 protein | CTD | PMID:16636311 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:735989 | 6480464 | Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of IRF1 protein] | CTD | PMID:16085646 PMID:16636311 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:735989 | 6480464 | IRF1 protein promotes the reaction [Tretinoin results in increased expression of XAF1 mRNA]; more ... | CTD | PMID:16530516 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:735989 | 6480464 | Dactinomycin inhibits the reaction [Tretinoin results in increased expression of IRF1 mRNA]; more ... | CTD | PMID:16636311 |
| amiodarone | increases expression | ISO | RGD:735989 | 6480464 | Amiodarone results in increased expression of IRF1 mRNA | CTD | PMID:19774075 |
| ammonium chloride | affects expression | ISO | RGD:2920 | 6480464 | Ammonium Chloride affects the expression of IRF1 mRNA | CTD | PMID:16483693 |
| azathioprine | decreases expression | EXP | | 6480464 | Azathioprine results in decreased expression of IRF1 mRNA | CTD | PMID:16473374 |
| benzene | decreases expression | EXP | | 6480464 | Benzene results in decreased expression of IRF1 mRNA | CTD | PMID:15120971 |
| benzo[a]pyrene | increases expression | ISO | RGD:735989 | 6480464 | Benzo(a)pyrene results in increased expression of IRF1 mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | affects expression | EXP | | 6480464 | Benzo(a)pyrene affects the expression of IRF1 mRNA | CTD | PMID:22342234 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] | CTD | PMID:20737476 |
| cadmium selenide | multiple interactions | ISO | RGD:735989 | 6480464 | [cadmium selenide co-treated with zinc sulfide] results in increased expression of IRF1 mRNA | CTD | PMID:22342292 |
| calcitriol | decreases expression | ISO | RGD:735989 | 6480464 | Calcitriol results in decreased expression of IRF1 mRNA | CTD | PMID:16002434 |
| chloroprene | decreases expression | ISO | RGD:2920 | 6480464 | Chloroprene results in decreased expression of IRF1 mRNA | CTD | PMID:23125180 |
| ciglitazone | multiple interactions | EXP | | 6480464 | ciglitazone inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] | CTD | PMID:12847270 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of IRF1 mRNA | CTD | PMID:18353800 |
| clofibric acid | affects expression | ISO | RGD:2920 | 6480464 | Clofibric Acid affects the expression of IRF1 mRNA | CTD | PMID:17602206 |
| cyclosporin A | increases expression | ISO | RGD:735989 | 6480464 | Cyclosporine results in increased expression of IRF1 mRNA | CTD | PMID:20106945 |
| dacarbazine | increases expression | ISO | RGD:735989 | 6480464 | Dacarbazine results in increased expression of IRF1 mRNA | CTD | PMID:17973783 |
| dacarbazine | multiple interactions | ISO | RGD:735989 | 6480464 | Isotretinoin promotes the reaction [Dacarbazine results in increased expression of IRF1 mRNA] | CTD | PMID:17973783 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of IRF1 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | multiple interactions | ISO | RGD:735989 | 6480464 | arsenic trioxide promotes the reaction [IFNG protein results in increased expression of IRF1 mRNA]; more ... | CTD | PMID:14668793 |
| diarsenic trioxide | decreases expression | ISO | RGD:735989 | 6480464 | arsenic trioxide results in decreased expression of IRF1 mRNA | CTD | PMID:20458559 PMID:22521957 |
| diarsenic trioxide | increases expression | ISO | RGD:735989 | 6480464 | arsenic trioxide results in increased expression of IRF1 mRNA | CTD | PMID:20953137 PMID:16914093 |
| diarsenic trioxide | increases expression | ISO | RGD:735989 | 6480464 | arsenic trioxide results in increased expression of IRF1 mRNA | CTD | PMID:16914093 PMID:20953137 |
| diarsenic trioxide | decreases expression | ISO | RGD:735989 | 6480464 | arsenic trioxide results in decreased expression of IRF1 mRNA | CTD | PMID:20458559 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of IRF1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:2920 | 6480464 | Dibutyl Phthalate results in decreased expression of IRF1 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | ISO | RGD:2920 | 6480464 | Diethylstilbestrol results in increased expression of IRF1 mRNA | CTD | PMID:17011747 |
| dimethylarsinic acid | increases expression | ISO | RGD:2920 | 6480464 | Cacodylic Acid results in increased expression of IRF1 mRNA | CTD | PMID:16122865 |
| divanadium pentaoxide | affects expression | ISO | RGD:735989 | 6480464 | vanadium pentoxide affects the expression of IRF1 mRNA | CTD | PMID:17459161 |
| furan | increases expression | ISO | RGD:2920 | 6480464 | furan results in increased expression of IRF1 mRNA | CTD | PMID:20124500 |
| hexachlorobenzene | decreases expression | ISO | RGD:2920 | 6480464 | Hexachlorobenzene results in decreased expression of IRF1 mRNA | CTD | PMID:15159207 |
| indole-3-methanol | multiple interactions | ISO | RGD:2920 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA | CTD | PMID:22129741 |
| isotretinoin | multiple interactions | ISO | RGD:735989 | 6480464 | Isotretinoin promotes the reaction [Dacarbazine results in increased expression of IRF1 mRNA] | CTD | PMID:17973783 |
| mangiferin | decreases expression | EXP | | 6480464 | mangiferin results in decreased expression of IRF1 mRNA | CTD | PMID:15135318 |
| mercury atom | affects response to substance | EXP | | 6480464 | IRF1 affects the susceptibility to Mercury | CTD | PMID:22578563 |
| mercury(0) | affects response to substance | EXP | | 6480464 | IRF1 affects the susceptibility to Mercury | CTD | PMID:22578563 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:735989 | 6480464 | Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein] | CTD | PMID:20525893 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2920 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA | CTD | PMID:22129741 |
| N-methyl-N-nitrosurea | decreases response to substance | EXP | | 6480464 | IRF1 protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:15240709 |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of IRF1 mRNA | CTD | PMID:15240709 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:2920 | 6480464 | Methylnitrosourea results in increased expression of IRF1 mRNA | CTD | PMID:17412507 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of IRF1 mRNA | CTD | PMID:18691550 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2920 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of IRF1 mRNA]; more ... | CTD | PMID:18691550 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2920 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IRF1 mRNA | CTD | PMID:18164116 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:2920 | 6480464 | Dimethylnitrosamine results in increased expression of IRF1 mRNA | CTD | PMID:14600272 |
| nickel sulfate | increases expression | ISO | RGD:735989 | 6480464 | nickel sulfate results in increased expression of IRF1 mRNA; more ... | CTD | PMID:20525893 |
| nickel sulfate | multiple interactions | ISO | RGD:735989 | 6480464 | Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein]; more ... | CTD | PMID:20525893 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:2920 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of IRF1 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:2920 | 6480464 | perfluorooctanoic acid results in decreased expression of IRF1 mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | ISO | RGD:2920 | 6480464 | Phenobarbital results in decreased expression of IRF1 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:735989 | 6480464 | Phenobarbital affects the expression of IRF1 mRNA | CTD | PMID:19159669 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of IRF1 mRNA | CTD | PMID:17426115 |
| pirinixic acid | decreases expression | ISO | RGD:2920 | 6480464 | pirinixic acid results in decreased expression of IRF1 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:2920 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of IRF1 mRNA | CTD | PMID:19162173 |
| puromycin | multiple interactions | ISO | RGD:735989 | 6480464 | Puromycin inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein] | CTD | PMID:20525893 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol analog results in increased expression of IRF1 mRNA | CTD | PMID:15652768 |
| silver atom | decreases expression | ISO | RGD:735989 | 6480464 | Silver results in decreased expression of IRF1 mRNA | CTD | PMID:22342292 |
| silver(0) | decreases expression | ISO | RGD:735989 | 6480464 | Silver results in decreased expression of IRF1 mRNA | CTD | PMID:22342292 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [IFNG results in increased expression of IRF1 mRNA] | CTD | PMID:17507688 |
| tamibarotene | increases expression | ISO | RGD:735989 | 6480464 | Am 80 results in increased expression of IRF1 mRNA | CTD | PMID:17229644 |
| tamibarotene | increases expression | ISO | RGD:735989 | 6480464 | Am 80 results in increased expression of IRF1 mRNA; more ... | CTD | PMID:15498508 PMID:17229644 |
| tamibarotene | increases expression | ISO | RGD:735989 | 6480464 | Am 80 results in increased expression of IRF1 mRNA | CTD | PMID:17229644 PMID:15498508 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of IRF1 mRNA | CTD | PMID:20937368 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of IRF1 mRNA | CTD | PMID:15003993 |
| tetrachloromethane | affects expression | ISO | RGD:2920 | 6480464 | Carbon Tetrachloride affects the expression of IRF1 mRNA | CTD | PMID:12734012 |
| titanium dioxide | increases expression | ISO | RGD:735989 | 6480464 | titanium dioxide results in increased expression of IRF1 mRNA | CTD | PMID:22342292 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol analog results in increased expression of IRF1 mRNA | CTD | PMID:15652768 |
| trimellitic anhydride | increases expression | ISO | RGD:2920 | 6480464 | trimellitic anhydride results in increased expression of IRF1 mRNA | CTD | PMID:21893156 |
| troglitazone | increases expression | ISO | RGD:735989 | 6480464 | troglitazone results in increased expression of IRF1 mRNA | CTD | PMID:19140230 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of IRF1 mRNA | CTD | PMID:19136453 |
| vanadium atom | increases activity | ISO | RGD:735989 | 6480464 | Vanadium results in increased activity of IRF1 protein | CTD | PMID:19000753 |
| vanadium(0) | increases activity | ISO | RGD:735989 | 6480464 | Vanadium results in increased activity of IRF1 protein | CTD | PMID:19000753 |
| vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of IRF1 mRNA | CTD | PMID:18930951 |
| zinc atom | multiple interactions | ISO | RGD:735989 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of IRF1 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:735989 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of IRF1 mRNA | CTD | PMID:18593933 |